CIDRAP newsletters options
The study from 10 Brazilian cities adds to mounting evidence that the two drugs shouldn't be used in the treatment of COVID-19.
Last week the nation's vaccination rate dropped slightly for the first time, partly due to the J&J vaccine pause.
Today the numbers soared even higher, with 332,358 new cases and 2,255 deaths.
A study assessing use of a medical mask under a cloth mask for COVID-19 has some scientists concerned.
Preliminary findings from a large analysis of pregnant women who received mRNA COVID-19 vaccines showed no obvious safety signals, Centers for Disease Control and Prevention (CDC) researchers reported yesterday in the New England Journal of Medicine.
"COVID-19 has really put a spotlight on the importance of preparedness."
More than 50% of all Americans and 80% of seniors have had at least one dose of vaccine.
Results confirm findings from earlier in the pandemic that highlighted racial disparities.
India's daily cases topped 300,000, the only country besides the United States to hit that level.
A study yesterday in Cell Reports Medicine shows the B117 variant, first identified in the United Kingdom in December, is 45% more transmissible than the original, wild-type COVID-19 virus, but Pfizer's mRNA vaccine protected elderly populations against infections caused by the variant.
A study of colistin-resistant Enterobacterales (CORE) isolates from patients in southeast Michigan found that increased age and prior antibiotic receipt were associated with increased risk of CORE colonization or infection, researchers reported today in Open Forum Infectious Diseases.
The country's prime minister addressed the nation about the steps officials are taking to get a handle on the massive surge, which is turning into the world's worst.
Agencies didn't perform in the roles identified for the emergency return of US citizens, the GAO says.
Also, NIH will fund a trial to test several existing medications for people to self-administer to treat COVID-19.
An analysis of extracorporeal membrane oxygenation (ECMO) use at 17 intensive care units (ICUs) in the greater Paris area during France's first COVID-19 wave reveal that 90-day survival was strongly linked to a hospital's earlier experience with the procedure. Investigators from France detailed their findings yesterday in The Lancet Respiratory Medicine.
CARB-X announced today that it is awarding Durham, North Carolina, biotech company Baebies Inc. up to $3.9 million to develop a rapid, easy-to-use diagnostic test for sepsis in newborns.
With thousands of new places to get a vaccine, 9 of 10 Americans live within 5 miles of an immunization site.
Brain abnormalities could explain the confusion and delirium of severe COVID-19.
"Big numbers can make us numb. But each one of these deaths is a tragedy for families, communities, and nations."
CARB-X announced today that it is awarding Phico Therapeutics of Cambridge, United Kingdom, up to $5.3 million to develop an intravenous bacteriophage drug to treat ventilator-associated pneumonia caused by Pseudomonas aeruginosa.
